Lawyer 'put loyalty to GSK over law'

Share this article:
Prosecutors told a Maryland federal court jury in late April that former GlaxoSmithKline associate general counsel Lauren Stevens put loyalty to the company above fidelity to the truth and the law when she covered up the company's illegal marketing of Wellbutrin.
She is charged with one count of obstructing an official proceeding, one count of falsifying and concealing documents, and four counts of making false statements. The first two charges carry a maximum of 20 years in prison and the others could bring terms of up to five years.
Stevens is charged with impeding an FDA 2002 and 2003 inquiry into the marketing of Wellbutrin for unapproved uses.
“This is a case about a lawyer who went too far, from aggressively representing her company to breaking the law,” said Department of Justice attorney Patrick Jasperse.
Stevens' attorney told the jury that she never intended to mislead FDA and that she relied on the advice of GSK's in-house attorneys and an outside law firm in preparing her responses for FDA. “Everything she did in this case was utterly inconsistent with an intent to deceive the government,” said defense attorney Reid Weingarten. He said she made a good faith effort to respond to the government while properly protecting her client. —JGD
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?